Yahoo Finance

Mereo BioPharma Sends Letter to Rubric Capital Management

LONDON, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), ("Mereo" or "the Company"), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today ...
Nasdaq

Rubric Capital Management Issues Open Letter to Xperi Inc. Stockholders in Response to Company’s Highly Misleading Investor Presentation

Upon reading the investor presentation issued by Xperi on April 30, 2024, we were struck by one, overriding thought: “What contempt this Board must have for its own stockholders.” While we are not ...
markets.financialcontent

Rubric Capital Management Sends Letter to Xperi Inc. Stockholders Highlighting Superior Qualifications and Skills of its Director Nominees, Thomas A. Lacey and Deborah S. Conrad

In its letter, Rubric underscored Xperi’s and its predecessor company’s poor total shareholder return under the watch of Mr. Habiger and Ms. Antonellis, and contrasted the superior qualifications, ...
streetinsider

Mereo BioPharma (MREO) Sends Letter to Rubric Capital Management

This letter responds in greater detail to Rubric’s assumptions and assertions. We also wish to explain how your proposals do not account for the Company’s ongoing contractual and clinical commitments ...